# A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis

> **NCT00160446** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 130 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Asoprisnil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00160446
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160446, "A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in the Treatment of Women With Endometriosis". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00160446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*